| Literature DB >> 33492550 |
Veronika S Biller1, Michael F Leitzmann2, Anja M Sedlmeier2, Felix F Berger2, Olaf Ortmann3, Carmen Jochem2.
Abstract
Sedentary behaviour is an emerging risk factor for several site-specific cancers. Ovarian cancers are often detected at late disease stages and the role of sedentary behaviour as a modifiable risk factor potentially contributing to ovarian cancer risk has not been extensively examined. We systematically searched relevant databases from inception to February 2020 for eligible publications dealing with sedentary behaviour in relation to ovarian cancer risk. We conducted a systematic review and meta-analysis, calculating summary relative risks (RR) and 95% confidence intervals (CI) using a random-effects model. We calculated the E-Value, a sensitivity analysis for unmeasured confounding. We tested for publication bias and heterogeneity. Seven studies (three prospective cohort studies and four case-control studies) including 2060 ovarian cancer cases were analysed. Comparing highest versus lowest levels of sedentary behaviour, the data indicated a statistically significant increase in the risk of ovarian cancer in relation to prolonged sitting time (RR = 1.29, 95% CI = 1.07-1.57). Sub-analyses of prospective cohort studies (RR = 1.33, 95% CI = 0.92-1.93) and case-control studies (RR = 1.28, 95% CI = 0.98-1.68) showed statistically non-significant results. Sensitivity analysis showed that an unmeasured confounder would need to be related to sedentary behaviour and ovarian cancer with a RR of 1.90 to fully explain away the observed RR of 1.29. Our analyses showed a statistically significant positive association between sedentary behaviour and ovarian cancer risk.Entities:
Keywords: Meta-analysis; Ovarian cancer; Sedentary behaviour; Systematic review
Mesh:
Year: 2021 PMID: 33492550 PMCID: PMC8417015 DOI: 10.1007/s10654-020-00712-6
Source DB: PubMed Journal: Eur J Epidemiol ISSN: 0393-2990 Impact factor: 8.082
Fig. 1PRISMA flow diagram depicting the process of study selection for meta-analysis
Study characteristics of the three cohort studies and four case–control studies of sedentary behaviour and ovarian cancer risk
| First author, year, country | Sample population and follow-up time | Number of cases and method of assessment | Assessment and categorisation of sedentary behaviour | Exposure, ovarian cancer endpoint and risk estimate included in main analysis | Confounding variables |
|---|---|---|---|---|---|
| Prospective cohort studies | |||||
| Ukawa et al., 2018, Japan [ | 34 758 women from the JACC Study, aged 40–79 years at baseline. Mean follow-up 19.4 years | 59 incident ovarian cancer cases identified by local medical records and linkage to state cancer registries | Self-reported TV-viewing time, categorised as < 2, 2–2.9, 3–3.9, 4–4.9 or ≥ 5 h/day | TV-viewing time ≥ 5 h/day, total OCa: HR = 1.81 [0.75–4.39] | Age, college education, family history of breast, ovarian or prostate cancer, body mass index, daily walking time, smoking status, alcohol consumption, parity (number of live births), age at menopause, age at menarche, hormone therapy, daily sleeping time |
| Hildebrand et al., 2015, USA [ | 63 972 women from the ACS CPSII-Nutrition Cohort, aged 50–74 years at baseline. Mean follow-up 19 years | 651 incident ovarian cancer cases identified by self-report and verified by medical records or linkage with state cancer registries, or by death certificate, and verified through registries | Self-reported leisure-time sitting, categorised as < 3, 3–5 or ≥ 6 h/day. Histological differentiation in total, serous and non-serous ovarian cancer | Leisure-time sitting ≥ 6 h/day, total OCa: RR = 1.44 [1.12–1.85] | Age, education, body mass index, smoking status, parity (number of live births), use of oral contraceptives, postmenopausal hormone use |
| update of: Patel et al., 2015, USA [ | |||||
| Patel et al., 2006, USA [ | |||||
| Xiao et al., 2013, USA [ | 96 247 women from the NIH-AARP Diet and Health Study aged 50–71 years at baseline. Mean follow-up 11 years | 467 incident ovarian cancers identified by linkage with 10 state cancer registries | Self-reported total sitting time, categorised as < 3, 3–4, 5–6 or ≥ 7 h/day | Total sitting time ≥ 7 h/day, epithelial OCa: | Age, race, education, smoking, parity (number of live births), age at menopause, age at menarche, oral contraceptive use, postmenopausal hormone use, marital status |
| Self-reported TV-viewing time, categorised as < 3, 3–4, 5–6 or ≥ 7 h/day | RR = 1.06 [0.81–1.39] | ||||
| Case–control studies | |||||
| Gazibara et al., 2013, Serbia [ | 80 ovarian cancer cases treated at the national referral centres for ovarian cancer Belgrade, Serbia, (mean age 56.1 years) and 160 cancer controls (mean age 56.7 years) between 2006–2008 | 80 ovarian cancer cases | Standardised interview, leisure-time sitting, categorised as ≤ 3 or ≥ 4 h/day | Leisure-time sitting ≥ 4 h/day, epithelial OCa: | Age, municipality of residence (matching factors) |
| OR = 1.8 [1.0–3.1] | |||||
| Lee et al., 2013, China [ | 500 ovarian cancer cases treated in four public hospitals in Guangzhou, China, (mean age 59.07 years) and 500 cancer controls (mean age 59.71 years) between 2006–2008 | 500 ovarian cancer cases | Standardised interview, total sitting time, categorised as ≤ 4, 4,5–8 or ≥ 8.5 h/day | Total sitting time ≥ 8,5 h/day, epithelial OCa: | Age, education level, family history of ovarian or breast cancer, body mass index, smoking status, parity, menopausal status, oral contraceptive use; |
| OR = 1.07 [0.77–1.48] | |||||
| Zhang et al., 2004, China [ | 254 ovarian cancer cases diagnosed in the past 3 years in Zhejiang province, China, (mean age 46.8 years) and 652 cancer controls (mean age 48 years) | 254 ovarian cancer cases | Standardised interview, occupational sitting time, categorised as < 2, 2–6 and > 6 h/day | Total sitting time > 10 h/day, epithelial OCa: | Age, education, locality, family history of ovarian cancer, body mass index, physical activity, smoking status, alcohol consumption, tea drinking, total energy intake, parity, menopausal status, oral contraceptive use, hormone therapy, tubal ligation, marital status, family income; |
| Standardised interview, TV-viewing time, categorised as < 2, 2–4 or > 4 h/day | |||||
| Standardised interview, other sedentary activities, categorised < 2, 2–4 or > 4 h/day | OR = 1.77 [1.0–3.1] | ||||
| Standardised interview, total sitting time, categorised as < 4, 4–10 or > 10 h/day | |||||
| Dosemeci et al., 1993, Turkey [ | 49 ovarian cancer cases treated at an oncological treatment centre in Istanbul, Turkey, and 244 cancer controls | 49 ovarian cancer cases | Job titles, occupational sitting time, categorised as < 2, 2–6 and > 6 h/day | Occupational sitting time > 6 h/day, total OCa: | Age, smoking, socioeconomic status |
| OR = 0.4 [0.1–1.9] | |||||
OCa ovarian cancer, JACC Study Japan Collaborative Cohort Study for Evaluation of Cancer Risk, ACS CPS-II Nutrition Cohort American Cancer Society Cancer Prevention Study II Nutrition Cohort, NIH-AARP Diet and Health Study National Institute of Health-American Association of Retired Persons Diet and Health Study, TV television, BMI body mass index, hours/day hours per day, kg/m2 kilogram per square meter, HR hazard ratio, RR relative risk, OR odds ratio, values in brackets indicate the corresponding 95% confidence interval (CI)
Fig. 2Forest plot of random-effects meta-analysis of adjusted risk estimates of high versus low sedentary behaviour in relation to ovarian cancer risk. The black square and the respective line represent the risk estimate and corresponding 95% confidence interval (CI) for each study. The diamond represents the summary relative risk with the corresponding CI for ovarian cancer risk based on case–control studies, cohort studies, and all studies combined, respectively. P, P-value (statistical significance); I2, heterogeneity among studies; RR, relative risk; RE Model, random effects mode
Stratification criteria, relative risk, difference between included ovarian cancer risk studies and results of random-effects meta-regression meta-analysis for each subgroup
| Stratification criteria | Number of included RRs | RR (high versus low SB) | 95% CI | I2 (%) | P(diff) |
|---|---|---|---|---|---|
| Total incident ovarian cancer | 7 | 1.29 | 1.07, 1.57 | 29.56 | NA |
| Prospective cohort studies | 3 | 1.28 | 0.98, 1.68 | 43.26 | |
| Case–control studies | 4 | 1.33 | 0.92, 1.93 | 41.42 | 0.9021 |
| Asia | 3 | 1.36 | 0.91, 2.03 | 39.80 | |
| Europe | 2 | 1.02 | 0.24, 4.26 | 68.66 | |
| North America | 2 | 1.24 | 0.92, 1.68 | 62.22 | 0.9104 |
| Total | 3 | 1.13 | 0.93, 1.38 | 0.01 | |
| Leisure-time | 3 | 1.34 | 0.95, 1.90 | 45.02 | |
| TV-viewing time | 3 | 1.54 | 0.79, 2.97 | 51.78 | |
| Occupational time | 2 | 1.06 | 0.23, 4.83 | 72.50 | 0.9018 |
| Self-administered questionnaire | 3 | 1.28 | 0.98, 1.68 | 43.26 | |
| Standardised interview | 3 | 1.42 | 0.97, 2.07 | 49.31 | |
| Job title assignment | 1 | 0.40 | 0.08, 1.90 | NA | 0.3232 |
| Adjusted for BMI | 4 | 1.36 | 1.08, 1.71 | 23.59 | |
| Not adjusted for BMI | 3 | 1.18 | 0.71, 1.95 | 54.24 | 0.5031 |
| Adjusted for family history | 3 | 1.36 | 0.91, 2.03 | 39.80 | |
| Not adjusted for family history | 4 | 1.28 | 0.98, 1.68 | 43.24 | 0.8421 |
| Adjusted for parity | 5 | 1.27 | 1.04, 1.54 | 31.24 | |
| Not adjusted for parity | 2 | 1.02 | 0.24, 4.26 | 68.66 | 0.6129 |
| Adjusted for age at menarche / menopause | 2 | 1.16 | 0.78, 1.74 | 21.94 | |
| Not adjusted for age at menarche / menopause | 5 | 1.36 | 1.09, 1.70 | 23.85 | 0.4008 |
| Adjusted for oral contraceptives | 4 | 1.25 | 1.02, 1.53 | 37.31 | |
| Not adjusted for oral contraceptives | 3 | 1.60 | 1.02, 2.49 | 0.00 | 0.3749 |
| Adjustment for hormone therapy | |||||
| Adjusted for hormone therapy | 4 | 1.35 | 1.05, 1.73 | 39.51 | |
| Not adjusted for hormone therapy | 3 | 1.19 | 0.72, 1.97 | 51.36 | 0.6191 |
| Adjusted for education | 5 | 1.27 | 1.04, 1.54 | 31.24 | |
| Not adjusted for education | 2 | 1.02 | 0.24, 4.26 | 68.66 | 0.6129 |
| Adjusted for alcohol use | 2 | 1.78 | 1.11, 2.86 | 0.00 | |
| Not adjusted for alcohol use | 5 | 1.23 | 1.00, 1.51 | 33.90 | 0.1777 |
| Adjusted for smoking status | 6 | 1.24 | 1.02, 1.51 | 26.55 | |
| Not adjusted for smoking status | 1 | 1.80 | 1.05, 3.10 | NA | 0.2468 |
RR relative risk, SB sedentary behaviour, CI confidence interval, I2 heterogeneity among studies, P(diff) P value for difference in the result of moderator analysis, NA not applicable, BMI body mass index